Tag: glycemic control

1. Tirzepatide was superior to placebo with regard to changes in HbA1c, serum glucose, body weight loss, and proportion of patients achieving HbA1c targets of less than 7.0%. 2. Compared to placebo, the proportion of adverse events with tirzepatide were mildly elevated. Evidence Rating Level: 1 (Excellent) Study Rundown: In many patients...
1. Time in range after 6 months was higher with rtCGM than with isCGM. 2. Participants on rtCGM scored better on the satisfaction subscale of the Diabetes Treatment Satisfaction Questionnaire status (mean difference of 2.34 points). Evidence Rating Level: 1 (Excellent) Study Rundown: Progress in the field of home glucose monitoring systems...
1. Semaglutide 2.4 mg combined with once weekly cagrilintide therapy was not associated with increase in adverse events compared to semaglutide alone. 2. Compared to control, combined cagrilintide and semaglutide improved glycemic parameters and mean body weight reduction at 20 weeks. Evidence Rating Level: 1 (Excellent)  Study Rundown: Semaglutide is a glucagon-like...
Image: PD  1. In a 20 year follow-up study (DIGAMI 1 trial), intensive insulin-based glycemic control for 3 months after an initial acute myocardial infarction (MI) in type 2 diabetics increased survival by 2.3 years compared to standard glycemic control.  2. The mortality benefits of intensive insulin-based glycemic control was most...
Image: PD 1.     Weight loss and glycemic control are improved in the short term to a greater extent in nonmorbidly obese diabetic patients who have undergone bariatric surgery relative to nonsurgical intervention. 2.     Gastric bypass was more effective than gastric banding for weight loss and glycemic control. 3.     Since the literature does...